Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $161.44 -0.11%
EPS Growth %: -5.5%
Financial Fact:
Total revenues: 0
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -5.5%
Financial Fact:
Total revenues: 0
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.07), $0.10 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
